Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. - Wikidata - awgldk - TriplyDB

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

http://www.wikidata.org/entity/Q42957300

about

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management Using germline genomics to individualize pediatric cancer treatments Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging.The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability.Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits.Risk and associated risk factors of hospitalization for specific health problems over time in childhood cancer survivors: a medical record linkage study Cardiovascular disease in adult survivors of childhood cancer.Review of cardiotoxicity in pediatric cancer patients: during and after therapy.Individual prediction of heart failure among childhood cancer survivors.NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage.Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity.Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas.Evidence-based risk assessment and recommendations for physical activity clearance: Consensus Document 2011.Prevention of Chemotherapy Induced Cardiomyopathy.Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts.Impact of chronic disease on emotional distress in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine.An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children.Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?Left ventricular twisting and untwisting motion in childhood cancer survivors.Ultrastructure and stereology of cardiomyocytes in the development of regenerative and plastic myocardial insufficiency during ontogeny.Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity Genetic variants inSLC22A17 and SLC22A7are associated with anthracycline-induced cardiotoxicity in children

P2860

Q24628695-A6424F50-F94A-46FF-BFC9-FA05B693B01F Q27003261-9BAF74AB-747D-4E31-A15E-61DD4D6965B4 Q28088408-03ABB2BC-2AB9-49C6-A2B0-3E8E2F396295 Q30450980-172188F1-9F31-4854-B976-97B0903096D8 Q30620316-B7F4B83E-58BD-4603-B68A-ABDAABBFAAC4 Q33675082-B42C539E-F7A8-45BF-BDB2-1D8B66281788 Q33679623-6E6DAD6C-46D5-46BF-87FF-C1E08907DCB0 Q34042984-A0E62366-A3C6-4723-8F0D-26BF96A4ADD1 Q35008126-C09F313A-D377-4BDF-BB37-B56080DFCF3F Q35040680-DE74FA86-EAC2-43B7-81BE-DD21E079FD4B Q35557142-675986D1-3E1C-4FFB-B85C-9791180F6A25 Q35754395-2E15AC3D-2A9F-4517-A6B7-388FDECBD75D Q35797623-7FDA8DC9-44E5-4AF8-B396-AF11D1F67946 Q35962903-5802BD06-6043-4C5F-B735-71EE75C99264 Q36004460-C1DD7D9D-E6ED-43D4-81B1-9D43F9EC5D84 Q36081540-7B3CF129-5644-449B-ACC9-3A3D3B25C84A Q36348525-51D82D6F-1BF6-4350-9B8E-56FADF22474C Q36384257-50F6511F-9278-4826-9204-57E8EE81C176 Q36597663-E5763F35-69CB-4FEF-9B65-74C73BC4C54B Q36732654-056F5FC1-D06D-43EB-9863-65949DB22898 Q36825438-1BC5D8E9-C181-4104-A338-261CCCC6DC6D Q36939536-C2818CDD-DB0F-4564-9D5C-10558F53C617 Q37038711-9B5BE29C-A1A8-49C9-94AA-B50AF6D638DE Q37728846-A642645C-3386-403B-BBDE-CA99ACE77B45 Q37908100-62F92C1C-E859-4E85-8FC0-B1296089E15B Q38639587-451F676F-2F5D-4276-821D-B933849786CF Q38823143-9D6DB2A9-E8B1-4082-A76C-A6A487AB0E5B Q38838517-CCC1DC07-47F6-49A2-AD15-81D342CE86C9 Q39323215-053737E0-63B3-4C70-ADF1-A6EDB4EBAFCD Q40529075-10CCE970-2E6C-44FC-A870-F1E9703640B1 Q41771261-C2639C3E-94A2-4D27-890B-EB1A82BF6329 Q42130469-0B649A4F-36BE-4694-A0C3-1924961AE5A4 Q42317413-B4A74FEE-274D-4A15-A227-743C4DA09392 Q45073135-4AAF4F64-DBAF-486F-AF6A-D1DC7F05492E Q46409053-C97C41C8-9735-40B4-A68E-8FAC131624CF Q48231823-E15591AF-4026-482F-839F-1DD9E1187BE9 Q50679970-FB94913A-8025-4F3A-80F2-D356C0F746A9 Q53178124-CDAEA923-8AFA-47A0-BC92-24EBAB19AA17 Q58696664-CEDA0D85-6732-4334-A357-DE04634AF0F6 Q58862883-E4B6AB2A-A066-46C0-A68E-903B6192A413

P2860

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

http://www.wikidata.org/entity/Q42957300

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

@en

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

@nl

type

label

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

@en

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

@nl

prefLabel

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

@en

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

@nl

P1433

Q42957300-8BC14684-F4A5-4BCA-8483-CC1D854557F7

P1476

Q42957300-13E64A13-AC69-4CDE-900B-EC17D12BE5EC

P2093

Q42957300-0C0E9B30-28BD-498E-B905-E327046F5D1C

Q42957300-10F8388E-C451-426D-88CC-265581FE6098

Q42957300-292E13EA-0789-42BA-9F02-9AEB9626EB85

Q42957300-52CD5AD7-3361-426C-BC91-9A8E2F4C1D65

Q42957300-7CB9556C-83B3-400F-B5AC-D85052B68EBD

Q42957300-8AAB263C-5210-4AA0-A81C-B48393B868B0

Q42957300-EDF8E02F-A3EE-4111-9442-7EDDD14DA28E

Q42957300-F1C39470-6B70-4A4B-803D-818258718FF8

Q42957300-FBF7BC00-9085-42E0-BF09-D3BD726AAB79

P304

Q42957300-393D9CCE-5007-4332-ADBC-BF02BF73ACA0

P31

Q42957300-6A345A63-800F-4A21-8002-B917AF3F62A3

P356

Q42957300-8FE39A3A-C6CA-4F08-9848-B1DB7BD5B681

P407

Q42957300-1AC33A18-D573-4875-9840-2BCEAD650E00

P433

Q42957300-198D2899-D128-4833-B6F4-4268BF378691

P478

Q42957300-9441F0DE-E64C-42DA-AF8E-B6EECB2BBC17

P50

Q42957300-CCF87DF5-0F6E-4B84-8078-C758F21E13ED

P577

Q42957300-67A5CB17-1AF8-48CA-B507-9308ECFEB315

P5875

Q42957300-8E80F4D5-7CFD-435B-A492-48E8B0FEF8A8

P698

Q42957300-60E14090-1D16-486B-AEF8-6B50085E17E3

P356

ARCHINTERNMED.2010.233

P1433

JAMA Internal Medicine

P1476

Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

@en

P2093

Caro C Koning

http://www.w3.org/2001/XMLSchema#string

Cor van den Bos

http://www.w3.org/2001/XMLSchema#string

Elvira C van Dalen

http://www.w3.org/2001/XMLSchema#string

Flora E van Leeuwen

http://www.w3.org/2001/XMLSchema#string

Foppe Oldenburger

http://www.w3.org/2001/XMLSchema#string

Helena J van der Pal

http://www.w3.org/2001/XMLSchema#string

Huib N Caron

http://www.w3.org/2001/XMLSchema#string

Leontien C Kremer

http://www.w3.org/2001/XMLSchema#string

Wouter E Kok

http://www.w3.org/2001/XMLSchema#string

P304

1247-1255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2010.233

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P50

Michael Hauptmann

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45366450

http://www.w3.org/2001/XMLSchema#string

P698

20660845

http://www.w3.org/2001/XMLSchema#string